国际皮肤性病学杂志    2004 30 (4): 265-267   ISSN: 2096-5540  CN: 32-1880/R   妊娠期人乳头瘤病毒的感染状况及母婴传播的研究进展 宋军, 孟庆琴, 马小玲 皖南医学院弋矶山医院皮肤性病科, 芜湖241001 收稿日期 2003-09-10  修回日期 null  网络版发布日期 null 参考文献  [1] Arena S, Marconi M, Ubertosi M, et al. HPV and pregnancy:diagnostic methods, transmission and evolution. Minerva Ginecol, 2002,54:225-237. [2] Czegledy J, Gergely L, Endrodi 1. Detection of human papillomavirus deoxyribonucleic acid by filter in situ hybridization during pregnancy.J Med Virol, 1989, 28:250-254. [3] Fife KH, Katz BP, Roush J, et al. Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy. Am J Obstet Gynecol, 1996, 174 (5):1487-1493. [4] Szepietowska M, Slodzinski H, Polz-Dacewicz M, et al. Evaluation of frequency human papillomavinus infections during pregnancy. Ginekol Pol, 2002, 73:662-665. [5] Armbruster-Moraes E, loshimoto LM, Leao E, et al. Prevalence of 'high risk' human papillomavirus in the lower genital tract of Brazilian gravidas. Int J Gynaecol Obstet, 2000, 69:223-227. [6] Fife KH, Katz BP, Brizendine EJ, et al. Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period. Am J Obstet Gynecol, 1999,180:1110. [7] Rando RF, Lindheim S, Hasty L, et al. Increased frequency of detection of human papillomavirus deoxyribonucleic acid in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol, 1989, 161:50. [8] Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, et al. High-risk human papillomavirus clearance in pregnant women:trends for lower clearance during pregnancy with a catch-up postpartum. Br J Cancer,2002, 87:75-80. [9] de Roda Husman AM, Walboomers JM, Hopman E, et al. HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR:the age-related pattern. J Med Virol,1995, 46:97-102. [10] Tenti P, Zappatore R, Migliora P,et al. Latent human papillomavirus infection in pregnant women at term:a case-control study. J Infect Dis, 1997, 176:277-280. [11] Chan PK, Chang AR, Tam WH, et al. Prevalence and genotype distribution of cervical human papillomavirus infection:Comparison between pregnant women and non-pregnant controls. J Med Virol,2002, 67:583-588. [12] Hagensee ME, Slavinsky J 3rd, Gaffga CM, et al. Seroprevalence of human papillomavirus type 16 in pregnant women. Obstet Gynecol,1999, 94:653-658. [13] Mittal R, Tsutsumi K, Pater A, et al. Human papillomavirus type 16 expression in cervical keratinocytes:role of progesterone and glucocorticoid hormones. Obstet Gynecol, 1993, 81:5-12. [14] Morales-Peza N, Auewarakul P, Juarez V,et al. In vivo tissue-specif-ic regulation of the human papillomavirus type 18 early promoter by estrogen, progesterone, and their antagonists. Virology, 2002, 294:135. [15] Veress G, Csiky-Meszaros T, Konya J, et al. Follow-up of human papillomavirus (HPV) DNA and local anti-HPV antibodies in cytologically normal pregnant women. Med Microbiol Immunol (Berl),1996, 185:139-144. [16] Sethi S, Muller M, Schneider A,et al. Serologic response to the E4,E6, and E7 proteins of human papillomavirus type 16 in pregnant women. Am J Obstet Gynecol, 1998, 178:360-364. [17] Syrjanen S, Puranen M. Human papillomavirus infections in children:the potential role of maternal transmission. Crit Rev Oral Biol Med,2000,11:259-274. [18] Puranen MH, Yliskoski MH, Saarikoski SV, et al. Exposure of an infant to cervical human papillomavirus infection of the mother is common. Am J Obstet Gynecol, 1997,176:1039-1045. [19] Wang X, Zhu Q, Rao H. Maternal-fetal transmission of human papillomavirus. Chin Med J (Engl), 1998,111:726-727. [20] Smith EM, Johnson SR, Cripe T,et al. Perinatal transmission and maternal risks of human papillomavirus infection. Cancer Detect Prev,1995, 19:196-205. [21] Watts DH, Koutsky LA, Holmes KK, et al. Low risk of perinatal transmission of human papillomavirus:results from a prospective cohort study. Am J Obstet Gynecol, 1998, 178:365-373. [22] Tenti P, Zappatore R, Migliora P, et al. Perinatal transmission of human papillomavirus from gravidas with latent infections. Obstet Gynecol, 1999, 93(4):475-479. [23] Kawana K, Yasugi T, Yoshikawa H, et al. Evidence for the presence of neutralizing antibodies against human papillomavirus type 6 in infants born to mothers with condyloma acuminata. Am J Perinatol,2003, 20(1):11-16. [24] Eppel W, Worda C, Frigo P,et al. Human papillomavirus in the cervix and placenta. Obstet Gynecol, 2000, 96 (3):337-341. 通讯作者: